The invention disclosed herein was made with Government support under a co-operative agreement CCU210852 from the Centers for Disease Control and Prevention, of the Department of Health and Human Services and under National Institutes of Health, National Cancer Institute award CA67391. Accordingly, the U.S. Government has certain rights in this invention.
Entry |
---|
Ades et al. (1989) Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection, J Epidemiol Commun Health 43, 53-60 (Exhibit 2). |
Booy et al. (1994) Finding a needle in a haystack: detection of a small protein (the 12-kDa VP26) in a large complex (the 200-MDa capsid of herpes simplex virus) , Proc Natl Acad Sci USA 91, 5652-5656 (Exhibit 3). |
Corey and Spear (1986) Infection with herpes simplex viruses, N Eng J Med 314, 686-691 (Exhibit 4). |
Crawford (1994) Epstein-Barr virus, In: Zuckerman et al., eds., Principles And Practice of Clinical Virology, 3d edn., New York, Wiley, pp. 109-134 (Exhibit 5). |
Hornef (1995) Coincidence of Epstein-Barr virus reactivation, cyto-megalovirus infection, and rejection episodes in renal transplant recipients, Transplantation 60, 474-480 (Exhibit 6). |
Tatman et al. (1994) Assembly of herpes simplex virus type 1 capsids using a panel of recombinant baculoviruses, J Gen Virol 75, 1101-1113 (Exhibit 7). |
Trus et al. (1995) Herpes simplex virus capsids assembled in insect cells infected with recombinant baculoviruses; structural authenticity and localization of VP26, J Virol 69, 7362-7366 (Exhibit 8). |
van Grunsven etl (1993) Gene mapping and expression of two immuno-dominant Epstein-Barr virus capsid proteins, J Virol 67, 3908-3916 (Exhibit 9). |